Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience

Sirimon Reutrakul¹, Matthew Genco², Harley Salinas³, Robert M Sargis³, Carlie Paul³, Yuval Eisenberg³, Jiali Fang², Rachel N Caskey², Sarah Henkle⁴, Sam Fatoorehchi⁴, Amanda Osta^{2

5}, Pavan Srivastava^{2

5}, Alexia Johnson⁶, Sarah E Messmer^{2

5}, Michelle Barnes^{2

5}, Sarida Pratuangtham⁷, Brian T Layden³

Affiliations

¹ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL sreutrak@uic.edu.
² Department of Medicine, University of Illinois at Chicago, Chicago, IL.
³ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL.
⁴ Department of Family Medicine, University of Illinois at Chicago, Chicago, IL.
⁵ Department of Pediatrics, University of Illinois at Chicago, Chicago, IL.
⁶ University of Illinois Hospital & Health Sciences System, Chicago, IL.
⁷ California Institute of Technology, Pasadena, CA.

Sirimon Reutrakul et al. Diabetes Care. 2020 Oct.

. 2020 Oct;43(10):e137-e138.

doi: 10.2337/dc20-1503. Epub 2020 Aug 7.

¹ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL sreutrak@uic.edu.
² Department of Medicine, University of Illinois at Chicago, Chicago, IL.
³ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL.
⁴ Department of Family Medicine, University of Illinois at Chicago, Chicago, IL.
⁵ Department of Pediatrics, University of Illinois at Chicago, Chicago, IL.
⁶ University of Illinois Hospital & Health Sciences System, Chicago, IL.
⁷ California Institute of Technology, Pasadena, CA.

No abstract available

Figures

1. Gómez AM, Umpierrez GE, Muñoz OM, et al. . Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol 2015;10:325–329 - PMC - PubMed
1. Spanakis EK, Levitt DL, Siddiqui T, et al. . The effect of continuous glucose monitoring in preventing inpatient hypoglycemia in general wards: the glucose telemetry system. J Diabetes Sci Technol 2018;12:20–25 - PMC - PubMed
1. Nair BG, Dellinger EP, Flum DR, Rooke GA, Hirsch IB. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care. 11 May 2020 [Epub ahead of print]. DOI: 10.2337/dc20-0670 - PubMed
1. U.S. Food and Drug Administration Coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely, 2020. Accessed 12 June 2020. Available from https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19....
1. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622–628 - PubMed